Time-homogeneous Markov process for HIV/AIDS progression under a combination treatment therapy: cohort study, South Africa

Table 8 Transition intensities for each CD4 baseline

Transition	2	3	4	5
1 to 2	3.1280	6.3180	12.760	25.780
1 to 6	0.0125	0.0203	0.0330	0.0537
1 to 7	0.0389	0.0560	0.0807	0.1163
2 to 1	0.6644	0.5991	0.5407	0.4870
2 to 3	0.2842	0.4054	0.5783	0.8249
2 to 6	0.0176	0.0184	0.0194	0.0203
2 to 7	0.0227	0.0278	0.0341	0.0417
3 to 2	0.2450	0.1658	0.1123	0.0760
3 to 4	0.2749	0.1781	0.1153	0.0747
3 to 6	0.0079	0.0088	0.0098	0.0108
3 to 7	0.0347	0.0332	0.0318	0.0305
4 to 3	1.3990	0.8116	0.4708	0.2731
4 to 5	0.8935	0.6913	0.5348	0.4138
4 to 6	0.0110	0.0011	0.0103	0.0099
4 to 7	0.0496	0.0510	0.0524	0.0539
5 to 4	13.140	5.3300	2.1620	0.8774
5 to 6	0.0192	0.0167	0.0145	0.0126
5 to 7	0.3747	0.2259	0.1362	0.0821

ISSN: 1742-4682